JORR

The Journal of Orthopedics Research and Rehabilitation welcomes scholarly papers inorthopaedic surgery, physical therapy and rehabilitation, neurosurgery, neurology and clinic anesthesiology and reanimation. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Index
Case Report
Atypical Milroy's disease with predominant unilateral involvement: a case report
Milroy's disease (MD), known as hereditary lymphedema type I, is a rare autosomal dominant primary lymphedema. It accounts for about twenty percent of all primary lymphedema. MD typically presents clinically with bilateral lower extremity lymphedema. Our case report describes a rare case of MD presenting with unilateral upper and lower extremity lymphedema in a patient admitted to our clinic. A 24-year-old woman who had been followed for lymphedema since the age of 8 was diagnosed with MD at our hospital by physical examination, venous Doppler ultrasound, whole-body lymphoscintigraphy, and molecular genetic testing. Partial improvement was observed with complete decongestive therapy, considered the gold standard treatment for lymphedema. Genetic counseling may be beneficial for the patient and family. Although MD is uncommon in the literature, many more studies are needed to identify carrier variants in the community.


1. Milroy WF. An undescribed variety of hereditary edema. <em>New York Med J.</em> 1892:12.
2. Bissonnette B. Syndromes: rapid recognition and perioperative implications. McGraw-Hill Medical Publushing Division; 2006.
3. Evans AL, Brice G, Sotirova V, et al. Mapping of primary congenital lymphedema to the 5q35.3 region. <em>Am J Hum Genet.</em> 1999;64(2):547-555. doi:10.1086/302248
4. Ghalamkarpour A, Debauche C, Haan E, et al. Sporadic in utero generalized edema caused by mutations in the lymphangiogenic genes VEGFR3 and FOXC2. <em>J Pediatr.</em> 2009;155(1):90-93. doi:10.1016/j.jpeds. 2009.02.023
5. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. <em>Cell.</em> 2010;140(4):460-476. doi:10.1016/j.cell.2010.01.045
6. Ferrell RE, Levinson KL, Esman JH, et al. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. <em>Hum Mol Genet.</em> 1998; 87(13):2073-2078. doi:10.1093/hmg/7.13.2073
7. Mellor RH, Hubert CE, Stanton AW, et al. Lymphatic dysfunction, not aplasia, underlies Milroy disease. <em>Microcirculation.</em> 2010;17(4):281-296. doi:10.1111/j.1549-8719.2010.00030.x
8. Connell F, Brice G, Mortimer P. Phenotypic characterization of primary lymphedema. <em>Ann N Y Acad Sci.</em> 2008;1131:140-146. doi:10.1196/annals. 1413.013
9. Brice G, Child AH, Evans A, et al. Milroy disease and the VEGFR-3 mutation phenotype. <em>J Med Genet.</em> 2005;42(2):98-102. doi:10.1136/jmg. 2004.024802
10. Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A. Cancer-associated secondary lymphoedema. <em>Nat Rev Dis Primers.</em> 2019;5(1):22. doi:10.1038/s41572-019-0072-5
11. Greene AK, Voss SD, Maclellan RA. Liposuction for Swelling in Patients with Lymphedema. <em>New Engl J Med.</em> 2017;377(18):1788-1789. doi:10.1056/nejmc1709275
12. Seo KS, Suh M, Hong S, Cheon GJ, Lee SU, Jung GP. The new possibility of lymphoscintigraphy to guide a clinical treatment for lymphedema in patient with breast cancer. <em>Clin Nucl Med.</em> 2019;44(3):179-185. doi:10. 1097/rlu.0000000000002443
13. Sarica M, Gordon K, van Zanten M, et al. Lymphoscintigraphic abnormalities associated with milroy disease and lymphedema-distichiasis syndrome. <em>Lymphat Res Biol.</em> 2019;17(6):610-619. doi:10. 1089/lrb.2019.0016
14. Forner-Cordero I, Mu&ntilde;oz-Langa J, Forner-Cordero A, DeMiguel-Jimeno JM. Predictive factors of response to decongestive therapy in patients with breast-cancer-related lymphedema. <em>Ann Surg Oncol. </em>2010; 17(3):744-751. doi:10.1245/s10434-009-0778-9
Volume 2, Issue 4, 2024
Page : 79-81
_Footer